Modeling of Charcot-Marie-Tooth disease in zebrafish.

Area of Science:

• Neurology
• Genetics
• Model Organisms

Background:

• Charcot-Marie-Tooth (CMT) is a prevalent inherited neuromuscular disorder causing progressive peripheral nerve degeneration, muscle weakness, and sensory loss.
• Current therapeutic options for CMT are limited, with over 50 implicated genes and diverse pathological mechanisms presenting significant challenges for research and drug development.

Purpose of the Study:

• To review the utility of zebrafish as a model organism for studying Charcot-Marie-Tooth (CMT) disease.
• To highlight how zebrafish models can advance understanding of CMT pathophysiology and guide therapeutic strategies.

Main Methods:

• Utilizing zebrafish for studying hallmark CMT features like motor deficits, sensory dysfunction, and skeletal abnormalities.
• Employing forward and reverse genetic screening and transgenic lines in zebrafish.
• Leveraging zebrafish as a platform for evaluating potential therapeutic interventions, including pharmacological compounds and gene therapy.

Main Results:

• Zebrafish models have provided insights into the functional roles of CMT-associated genes and the impact of pathogenic mutations.
• These models effectively recapitulate key aspects of CMT, including motor and sensory deficits.
• Zebrafish facilitate the investigation of diverse pathological mechanisms underlying CMT.

Conclusions:

• Zebrafish represent a robust and versatile model for dissecting CMT pathophysiology and genetic complexities.
• The use of zebrafish models is crucial for identifying and testing novel therapeutic interventions for CMT.
• Further development and application of zebrafish models hold significant promise for future CMT treatments.